TY  - BOOK
AU  - Weissman, Neil J
TI  - Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
SN  - 0028-4793
PY  - 2018///
KW  - *Anti-Obesity Agents/tu [Therapeutic Use]
KW  - *Benzazepines/tu [Therapeutic Use]
KW  - *Cardiovascular Diseases/co [Complications]
KW  - *Hypoglycemia/ci [Chemically Induced]
KW  - *Obesity/dt [Drug Therapy]
KW  - *Overweight/dt [Drug Therapy]
KW  - *Weight Loss/de [Drug Effects]
KW  - Aged
KW  - Anti-Obesity Agents/ae [Adverse Effects]
KW  - Aortic Valve Insufficiency/ci [Chemically Induced]
KW  - Benzazepines/ae [Adverse Effects]
KW  - Cardiovascular Diseases/ci [Chemically Induced]
KW  - Cardiovascular Diseases/ep [Epidemiology]
KW  - Diabetes Mellitus, Type 2/co [Complications]
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Hypertension, Pulmonary/ci [Chemically Induced]
KW  - Male
KW  - Middle Aged
KW  - Obesity/co [Complications]
KW  - Overweight/co [Complications]
KW  - Risk Factors
KW  - MedStar Heart & Vascular Institute
KW  - Journal Article
UR  - https://dx.doi.org/10.1056/NEJMoa1808721
ER  -